Which precursor is named. NMN and NR are different molecules and are not interchangeable milligram for milligram.
Whether the milligram figure is per capsule or per serving of several capsules. The catalog records per serving.
Whether a certificate of analysis (CoA) is published for the batch you buy. The catalog only records whether the brand lists one.
Added ingredients (resveratrol, TMG, quercetin) are listed with their own amounts below. Read them separately.
Amounts are per label serving as recorded in the catalog and are not a recommendation. Testing status reflects what the brand lists. Nothing here is medical advice.
Editorial score and research-dose calculations
These calculations describe our scoring method. They are not a recommended dose or proof of benefit from this product.
RESHAW 2020(Resveratrol)12 months of 150 mg twice daily in postmenopausal women showed no cognitive benefit. Studied at 150 mg. This product: 200 mg.
How we scored this productShow the full breakdown▾
Dose vs. studies (50%)iWhy 6.0 of 10. Primary ingredient is NMN (evidence grade B). It delivers 400 mg, inside the studied range of 250–900 mg. Read the rule →6.0
Transparency (20%)iWhy 3.0 of 10. Earned points for all doses disclosed. Lost points for no public certificate of analysis and no independent third-party testing. Read the rule →3.0
Value (10%)iWhy 7.8 of 10. One day at the trial dose costs about $1.64. That is more expensive than average (169 of 313 by cost per effective day). Read the rule →7.8
Formulation (10%)iWhy 5.0 of 10. No published absorption advantage or disadvantage on file. The default of 5 is not a criticism. Read the rule →5.0
Default. No absorption data on file.
Safety (5%)iWhy 5.0 of 10. Baseline 5.0. Third-party testing adds 2.0. Public lab certificate adds 1.5. NSF, USP or Informed Choice certification adds 1.5. Active safety signal subtracts 3.0. Read the rule →5.0
Community sentiment (5%)iWhy 7.1 of 10. No external reviews found, so community sentiment defaults to neutral. Community never counts as clinical evidence. Read the rule →7.1
CompositeiHow this 4.7 is built. 0.50 × 6.0 + 0.20 × 3.0 + 0.10 × 7.8 + 0.10 × 5.0 + 0.05 × 5.0 + 0.05 × 7.1 = 4.7 out of 10. Safety caps applied after.4.7
4.7composite
Dose vs. studies50%6.0
Transparency20%3.0
Value10%7.8
Formulation10%5.0
Safety5%5.0
Community5%7.1
Evidence gates dose: the evidence grade sets the ceiling, and the dose decides how much of that ceiling the product reaches. Value = inverse of price-per-trial-dose-day. Community = mean sentiment of external reviews. Safety caps applied after weighting.
This score is our editorial judgment, not a scientific standard. We combine published evidence, dose, price, transparency, and consumer signals into one composite: this is our method, not a peer-reviewed clinical rating. A higher score means a product does better on the factors we weight, not that it is medically proven to work.
This Doctor's Best Doctor's Best NMN+ scores 5.5, making it below the site average. It delivers 400mg of NMN, inside the studied range of 250–900mg with grade B evidence (promising human data, not yet comprehensive). The quality transparency (3.0) is limited by the lack of third-party testing. At $1.64/day it's among the more expensive options in NAD+ booster.
What drives the score up
Dose-evidence score of 6.0 shows decent alignment with trial doses.
NMN is dosed at the full research level with grade B evidence (promising human data, not yet comprehensive).
What drags it down
Resveratrol (200mg is 40% of the 500mg trial dose) is significantly under-dosed.
Panax ginseng (50mg is 1% of the 4500mg trial dose) is significantly under-dosed.
No third-party testing, which caps the quality transparency.
Quality transparency of 3.0 is below the site average.
At $1.64/day it's on the expensive side.
Why you'd choose it
You want NMN from a Doctor's Best product.
Why you might skip it
You want third-party verified purity.
You want a product with a publicly available CoA.
You need a full trial dose of resveratrol (this product under-doses it).
Question 1
Does the molecule work?
The science behind each active ingredient, independent of which brand sells it.
A NAD+ building block that has become the most-hyped longevity molecule.
5 landmark RCTs · US: FDA reversed exclusion 29 September 2025; NDIN 1247 and NDIN 1259 reinstated 2 December 2025; NDIN 1444 (β-NMN, Effepharm) response 28 January 2026. NMN is a dietary ingredient again; each marketer still needs NDIN coverage. · EU: Unauthorised Novel Food; EFSA positive safety opinion adopted 4 March 2026 at up to 300 mg/day (β-NMN, EffePharm dossier). Commission listing pending.
A classic adaptogenic root containing ginsenosides, studied in multiple human trials for cognitive performance in aging and mild cognitive impairment.
1 landmark RCT · US: Dietary supplement under DSHEA. · EU: Panax ginseng root is an established traditional herbal medicinal product under the EU Traditional Herbal Medicinal Products Directive in several member states.
Full ingredient breakdown
Every active in this formula, its declared dose per serving, the dose used in the primary human trial, how much of that trial dose this product delivers, and the evidence grade for the ingredient itself.
Percentages are dose per serving ÷ primary trial dose. Below 50% means the formula is unlikely to reproduce the trial outcome for that active. Grade A = multiple large human RCTs. Grade F = no human evidence. How grades work. Full glossary →
Question 2
Is this bottle good?
The specific product: dose, price, transparency, and what buyers report.
Dose vs research
100% of trial dose
Meets or exceeds the published effective dose
Cost at trial dose
$1.64/day at trial dose
What one effective daily dose actually costs
Transparency
3.0/10 · No public lab certificate
No third-party testing disclosed
Consumer signals
2 reviews across platforms · 4.5/5 · medium confidence
Operational signal only, never used as clinical evidence
Question 3
What's the catch?
Safety flags, transparency gaps, dosing concerns, and recurring buyer complaints.
Hard numbers and independently checked status. Expand each block for its source.
The numbers
Price
$39
per bottle · 30 servings
Dose vs. research
of trial dose 100%
of published effective dose
$ / day at studied dose
$1.64
what one effective daily dose costs
$ / g active
$1.54
per gram of active substance
Independently checked
Data verification
COA status
Not public
Evidence grade
BCCB
Per-ingredient breakdown
BNMN
CResveratrol
CRhodiola Rosea
BPanax ginseng
All product data is checked against original sources. Prices, doses, and testing status are updated when product pages change. Evidence grades are reviewed when new human RCTs are published. Read how we verify.
NMNAbsorption varies wildly by form. Sublingual and liposomal claim better uptake but human head-to-head data is limited.
Resveratrol"Resveratrol" products that don't specify trans-isomer content are unmeasurable in practice. Cis-resveratrol is biologically inactive.
Rhodiola RoseaCan be stimulating; take earlier in day.
Panax ginsengCan cause insomnia or overstimulation in sensitive individuals, especially taken late in the day; potential interaction with blood thinners (warfarin) and diabetes medications (additive glucose-lowering effect); products vary widely in ginsenoside standardization.
Editorial notes
NMN 400 mg plus resveratrol 200 mg, rhodiola 200 mg, and American ginseng 50 mg per 2-capsule serving. Delayed-release veggie capsules. 30 servings per container.
If you are the manufacturer or brand owner of Doctor's Best NMN+ and believe any data on this page is incorrect (wrong dose, wrong ingredient, wrong price, missing certification, outdated status), you can request a correction.
We review every request, verify it against primary sources, and publish any accepted change with a dated note. Corrections from brand owners are treated the same as corrections from anyone else: verified before they move.